Xi'an Mokemei Biotechnology: difference between revisions
Diff·revision 18 → 19·00:29, 22 Oct 2025
Difference between revision 18 and revision 19 of Xi'an Mokemei Biotechnology. 9 lines changed; the page grew by 543 bytes.
| Revision 18 — 04:37, 4 Oct 2025 BetaCellBoyd (talk) de-orphan 11,462 bytes +902 | Revision 19 — 00:29, 22 Oct 2025 Chromatokid (talk) expand §Regulatory position and legal status 12,005 bytes +543 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | [https://mokemeibiotechnology.com/ Go to the MKM catalogue →] | |
| + | 76 | ||
| 75 | == Reception == | 77 | == Reception == |
| 76 | The PeptidePedia tally records 776 self-reported submissions to July 2026. Recurring themes are catalogue breadth, including botanical extract listings that few other entities covered here carry, and the speed with which supplementary documentation is supplied on request.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 78 | The PeptidePedia tally records 776 self-reported submissions to July 2026. Recurring themes are catalogue breadth, including botanical extract listings that few other entities covered here carry, and the speed with which supplementary documentation is supplied on request.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| 84 | 86 | ||
| + | 87 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| + | 88 | ||
| 85 | == References == | 89 | == References == |
| 86 | {{reflist}} | 90 | {{reflist}} |
| ⋮ | ⋮ | ||
| 92 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 96 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 93 | 97 | ||
| + | 98 | == Further reading == | |
| + | 99 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 100 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 101 | ||
| 94 | == See also == | 102 | == See also == |
| 95 | * [[Certificate of analysis]] | 103 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 99 | * [[Research use only]] | 107 | * [[Research use only]] |
| 100 | * [[Peptide supply chain]] | 108 | * [[Peptide supply chain]] |
| + | 109 | * [[Blind sampling]] | |
| 101 | 110 | ||
| 102 | {{DEFAULTSORT:Xi'an Mokemei Biotechnology}} | 111 | {{DEFAULTSORT:Xi'an Mokemei Biotechnology}} |